243
Views
3
CrossRef citations to date
0
Altmetric
Articles

Thrombocytopenia and platelet count recovery in patients with sepsis-3: a retrospective observational study

, , & ORCID Icon
Pages 612-620 | Received 05 Apr 2021, Accepted 04 Aug 2021, Published online: 27 Aug 2021
 

Abstract

Thrombocytopenia is common in critical illness. But there are no studies that focus on thrombocytopenia and platelet recovery in Sepsis-3 patients. We employed a large database to identify sepsis based on Sepsis-3 criteria. Patients were grouped by nadir platelet count during ICU, propensity score matching was used to eliminate covariates imbalance, multivariable cox proportional hazard model was used for evaluating mortality. A total of 9709 patients were enrolled based on Sepsis-3, 1794 (18%) patients developed thrombocytopenia, with 858 (8.8%) exhibiting thrombocytopenia at ICU admission (prevalent), 891 (9.2%) developed thrombocytopenia during ICU stay (incident). In the incident thrombocytopenia group, survivors exhibited higher nadir platelet count, higher rate in platelet count recovery and shorter time to platelet recovery compared to non-survivors. Platelet recovery was not observed until 1 days (IQR, 1–2) after weaning of mechanical ventilation and 1 days (IQR, 1–3) after discontinuation of vasopressor in survivors of incident thrombocytopenia. Furthermore, thrombocytopenia was associated with longer duration of ICU length of stay, longer duration of mechanical ventilation and vasopressor use compared to no thrombocytopenia. Moderate (20–50 × 109/L) and severe (<20 × 109/L) thrombocytopenia group showed increased 28 days mortality compared to no thrombocytopenia, while the mortality rate between mild (51–100 × 109/L) and no thrombocytopenia group (≥100 × 109/L) showed no significant difference. Taken together these data revealed that thrombocytopenia occurred in 18% Sepsis-3 patients; platelet recovery occurred more frequent and earlier in survivors; platelet recovery was not observed until clinical improvement. Thrombocytopenia in Sepsis-3 demonstrated increased disease severity, and patients with platelet count <50 × 109/L showed increased 28 days mortality.

Acknowledgements

This study was financially supported by the National Natural Science Foundation of China (82002088 to Zhengzheng Yan); The president fund of Nanfang Hospital (No. 2019Z021 to Zhengzheng Yan). We would like to thank Editage (www.editage.cn) for English language editing.

Authorship contributions

Hui. Zhou extracted data from the MIMIC-III database, Hui. Zhou, Zhengzheng. Yan designed the research and guided the literature review. Zhifeng Li and Hui Liang participated in the processing and analysing the data. Hui. Zhou, Zhengzheng. Yan wrote the manuscript.

Disclosure statement

The authors declare no competing financial interest.

Additional information

Funding

This work was supported by the National Natural Science Foundation of China [82002088]; President Foundation of Nanfang Hospital, Southern Medical University [No. 2019Z021].

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.